Biomarkers may help predict risk of Alzheimer’s disease

Biomarkers may help predict risk of Alzheimer’s disease in patients with mild cognitive impairment – Several cerebrospinal fluid (CSF) biomarkers showed good accuracy in identifying patients with mild cognitive impairment who progressed to Alzheimer’s disease, revealed by US researchers in JAMA.

New iPS therapy pioneered for heart attacks

Induced pluripotent stem cells repair heart, Mayo Clinic study shows — New iPS therapy pioneered for heart attacks. – Induced pluripotent stem (iPS) cells can be used to treat heart disease, revealed by researchers at Mayo Clinic, USA. iPS cells are stem cells converted from adult cells.

Improved behavior and sleep after adenotonsillectomy in children

Adenotonsillectomy may offer long-term benefits for children with breathing problems during sleep – Children with sleep-related breathing disorders appear to sleep better after adenotonsillectomy — surgery to remove their tonsils and adenoids — than they did before the procedure, but progress declines after six months.

Parental stress may increase asthma risk in children

US study finds link between parental stress, air pollution, and children?s risk for developing asthma. – Children with stressed out parents may be more susceptible to developing asthma (Childhood asthma) associated with environmental triggers such as high levels of traffic-related pollution and tobacco smoke, revealed by researchers.

Orexigen’s Contrave trials successful for obesity treatment

Contrave Helps Obese Patients Initiate and Sustain Meaningful Weight Loss, Improves Multiple Cardiometabolic Risk Factors and Reduces Food Cravings. – Orexigen Therapeutics, Inc. (Nasdaq: OREX) announced that all three remaining Phase 3 trials evaluating Contrave(R) (bupropion SR/naltrexone SR), its investigational drug for the treatment of obesity, met their co-primary endpoints.

Seasonal influenza vaccine for 2009-2010 approved by US

U.S. Food and Drug Administration (FDA) Approves Vaccine for 2009-2010 Seasonal Influenza. – The U.S. Food and Drug Administration announced that it has approved a vaccine for 2009-2010 seasonal influenza in the United States. The seasonal influenza vaccine will not protect against the 2009 H1N1 influenza virus.

Lupus drug Benlysta effective for SLE patients

Lupus Research Institute Highly Encouraged by Benlysta Trial Results — First Phase 3 Lupus Drug Trial in Decades to Show Effectiveness. – Human Genome Sciences, Inc. (Nasdaq: HGSI) and GlaxoSmithKline PLC (GSK) announced that BENLYSTA (belimumab, formerly LymphoStat-B?) met the primary endpoint in BLISS-52, the first of two pivotal Phase 3 trials in patients with serologically active systemic lupus erythematosus (SLE).

Breast cancer drug Abraxane promising for malignant melanoma treatment

Cancer Center Studies Lead to New Trials for Malignant Melanoma Treatment — Breast cancer drug Abraxane promising for metastatic malignant melanoma treatment. – An approved breast-cancer drug nab-paclitaxel, trade named Abraxane, has been found promising in clinical trial for the treatment of metastatic malignant melanoma, revealed by researchers.

298 positive for Influenza A H1N1 recorded in India

Update on Influenza a (H1N1) as on 19th July 2009 — 298 positive for Influenza A H1N1 recorded in India – Health screening of passengers coming from affected countries to India is continuing in 22 International airports. 50,858 passengers have been screened on 18.7.2009 of which 40,675 passengers were from affected countries.

Exercise helps stroke patients recover faster

Mayo Clinic researchers find previous exercise helps stroke patients recover faster – A person who has exercised regularly prior to the onset of a stroke appears to recover more quickly, say researchers from Mayo Clinic in Florida, USA, in the Journal of Neurology, Neurosurgery & Psychiatry.

FASD children have more behavioral problems than ADHD children

Children with FASD have more severe behavioral problems than children with ADHD – Children with fetal alcohol spectrum disorders (FASD) have a high risk of psychiatric problems, particularly attention deficit hyperactivity disorder (ADHD), conduct disorder, or both.

Thalidomide does not improve survival in lung cancer

JNCI news brief: Thalidomide does not improve survival in small cell lung cancer – Treating patients with thalidomide in combination with chemotherapy for small cell lung cancer (SCLC) did not improve their survival but did increase their risk of blood clots, revealed by researchers.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | SpiritIndia